3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma ARC

ARCpoint Inc.

ARC TSXV Biotech & Pharma

Stock factsheet

TickerARC
ExchangeTSXV
ISIN
WKN
SectorBiotech & Pharma
Size class Nano Cap
Market capitalisation 236.716 USD As of 2026-08-04

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.

Company profile

ARCpoint is a healthcare technology company that owns and develops MAPL, a multi-tenant software platform for clinical lab ordering, scheduling and results delivery used by laboratories, collection sites and other healthcare service providers in the United States. ARCpoint's Class A Subordinate Voting Shares trade on the TSX Venture Exchange under the symbol 'ARC'.

Company description as published by the issuer via TMX Money.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
ARCpoint Inc.ARC TSXV236.716 USD
CENTR Brands Corp. CNTRCSE 248.579 USD
NAVCO Pharmaceuticals Inc. NAVTSXV 203.416 USD
Digicann Ventures Inc. DCNN.XCSE 171.483 USD
Ultra Brands Ltd. ULTACSE 151.002 USD
NanoSphere Health Sciences Inc. NSHSCSE 146.498 USD
Vibe Growth Corporation VIBECSE 346.358 USD

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.